Molecular Instruments, Inc.

Molecular Instruments, Inc. is a biotech company in Los Angeles, United States, founded in 2021. It has raised $4.0M across 4 rounds, most recently a $307K Grant in September 2025.

In Situ Hybridization + Immunofluorescence

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$4.0M
Last Round
$307K GrantSep 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 1 investor for this company. The full record is or through the API.

About

Molecular Instruments designs and synthesizes kits for multiplex, quantitative, high-resolution bioimaging in academic research, drug development, clinical pathology, and diagnostics. It provides custom assay design and development for life sciences and pharmaceutical laboratories and businesses. The company also offers nucleic acid sequence design and analysis services for agricultural and veterinary enterprises.

Summary

It lists 11–50 employees. It has raised $4.0M in total across 4 rounds, most recently a $307K Grant round in Sep 2025. Investors include National Institutes of Health.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase I (NIH)Sep 2025
$307K

Sign up to see all 4 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Molecular Instruments, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/molecular-instruments-inc"><img src="https://indexed.vc/api/badge/company/molecular-instruments-inc" alt="Molecular Instruments, Inc. on Indexed.vc" width="260" height="76" /></a>